New York’s Medicaid financing technique—significantly its use of a managed care group (MCO) tax—has come beneath renewed federal scrutiny amid latest legislative proposals and regulatory developments. The federal reconciliation invoice, often known as the One Large Lovely Invoice Act (OBBBA), alongside newly proposed steering from the Facilities for Medicare & Medicaid Providers (CMS), may considerably affect how New York and different states construction healthcare-related tax mechanisms used to attract down federal Medicaid matching funds.
Part 44132 of the OBBBA would set up a ten-year moratorium on the creation or growth of supplier and MCO taxes. Underneath this proposal, states could be prohibited from adopting new healthcare-related taxes or growing current ones until they had been enacted earlier than the efficient date of the laws. Even when a tax complies with federal necessities—similar to being broad-based, uniformly utilized, and never straight redistributive—it will stay frozen at its present construction during the moratorium.[1]
This legislative motion is strengthened by CMS’s proposed rule issued in April 2025, which might enhance scrutiny of waiver requests for narrowly tailor-made supplier taxes. The CMS reality sheet outlines how the rule goals to make sure that such taxes don’t disproportionately profit the suppliers who fund them and that they meaningfully redistribute prices throughout a supplier class. CMS signaled that future approvals could be based mostly not solely on statistical compliance with redistribution formulation, but in addition on substantive proof that the taxes usually are not structured to ensure repayments by way of Medicaid.
New York’s FY 2025 finances projected roughly $3.7 billion in income from its MCO tax, supposed to help Medicaid program enhancements, together with base fee changes and focused funds to suppliers. Nevertheless, in keeping with CMS correspondence and discussions shared on the Could 2025 MACPAC assembly, the federal authorities is predicted to approve solely about $2.1 billion in matching funds beneath present coverage requirements.
This shortfall has triggered a evaluation by New York State officers, with studies indicating that the state could must restructure or change parts of the MCO tax mechanism. As of June 2025, the New York State Division of Well being has not issued up to date steering or notifications to suppliers relating to potential modifications to reimbursement or supplemental funding. Nevertheless, information protection and finances briefing supplies verify that the Governor’s Workplace is working with CMS and legislative leaders to guage choices for FY 2026 and past.
New York shouldn’t be alone. States similar to California, Michigan, and Pennsylvania are additionally assessing their supplier tax frameworks in response to tighter federal requirements and the proposed legislative freeze. Many of those states have traditionally used focused healthcare-related taxes as instruments to safe further federal funding for Medicaid. Underneath the OBBBA and new CMS guidelines, these methods would require higher alignment with redistributive rules and transparency necessities.
For context, the foundational guidelines governing supplier taxes seem in 42 U.S.C. § 1396b(w) and are carried out by way of 42 C.F.R. § 433.68. These guidelines require taxes to use throughout a broad base of suppliers, to be uniformly imposed, and to not disproportionately profit anyone group of taxpayers. The reconciliation invoice doesn’t change these requirements—it merely imposes a statutory moratorium on modifications that might in any other case have been evaluated beneath the present waiver course of.
For suppliers working in New York, the sensible results of those developments usually are not but totally identified, however preparation is prudent. Suppliers could want to monitor bulletins from the New York Division of Well being, reassess their present funding assumptions, and consider how federal match uncertainty may have an effect on supplemental funds. Whereas reimbursement modifications have but to be carried out, the alignment of federal laws and administrative rulemaking signifies that states could quickly face binding constraints on Medicaid financing flexibility.
As steering evolves and legislative proposals transfer ahead, healthcare suppliers, Medicaid plans, and different stakeholders ought to put together to navigate these modifications.
FOOTNOTES
[1] Proposed in legislative summaries; pending invoice textual content.